We are live on ! Find out more
RP

Riverbridge Partners Portfolio holdings

AUM $3.58B
1-Year Est. Return 4.02%
This Fund
S&P 500
This Quarter Est. Return
+8.91%
1 Year Est. Return
+4.02%
3 Year Est. Return
+40.43%
5 Year Est. Return
+44.7%
10 Year Est. Return
+473.33%
AUM
$8.2B
AUM Growth
+$191M
Cap. Flow
-$291M
Cap. Flow %
-3.55%
Top 10 Hldgs %
28.54%
Holding
209
New
7
Increased
42
Reduced
110
Closed
35

Top Sells

Rank Stock Value
1
FAST icon
Fastenal
FAST
+$45.6M
2
CSGP icon
CoStar Group
CSGP
+$41.7M
3
MEDP icon
Medpace
MEDP
+$27.3M
4
ANSS
Ansys
ANSS
+$27.2M
5
ECL icon
Ecolab
ECL
+$24.6M

Sector Composition

Rank Sector Weight
1 Technology 38.77%
2 Healthcare 22.9%
3 Industrials 12.81%
4 Consumer Discretionary 10.19%
5 Consumer Staples 4.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ALRM icon
26
Alarm.com
ALRM
$2.71B
$118M 1.44%
1,626,402
-40,707
-2% -$2.76M
PRVA icon
27
Privia Health
PRVA
$2.6B
$106M 1.29%
5,399,662
+804,304
+18% +$17M
CRM icon
28
Salesforce
CRM
$210B
$97.6M 1.19%
323,937
-14,012
-4% -$4.04M
ALGN icon
29
Align Technology
ALGN
$10.4B
$95.7M 1.17%
291,709
+1,746
+0.6% +$512K
VRSK icon
30
Verisk Analytics
VRSK
$23.4B
$93.6M 1.14%
396,969
-12,339
-3% -$2.96M
VEEV icon
31
Veeva Systems
VEEV
$43.2B
$92.9M 1.13%
401,154
-15,560
-4% -$3.36M
DSGX icon
32
Descartes Systems
DSGX
$6.83B
$89.4M 1.09%
976,613
+261,688
+37% +$23M
ADI icon
33
Analog Devices
ADI
$175B
$89M 1.09%
450,071
-17,353
-4% -$3.34M
NOW icon
34
ServiceNow
NOW
$147B
$88M 1.07%
576,880
-24,280
-4% -$3.68M
DV icon
35
DoubleVerify
DV
$2.09B
$87.8M 1.07%
2,497,400
-63,988
-2% -$2.38M
CCC
36
CCC Intelligent Solutions
CCC
$3.89B
$86.2M 1.05%
7,204,264
-174,178
-2% -$1.99M
EXPO icon
37
Exponent
EXPO
$3.2B
$83.1M 1.01%
1,005,347
-22,299
-2% -$1.84M
CRL icon
38
Charles River Laboratories
CRL
$13B
$82.3M 1%
303,778
+3,088
+1% +$737K
SQSP
39
DELISTED
Squarespace, Inc.
SQSP
$82.2M 1%
2,255,451
-37,673
-2% -$1.22M
RGEN icon
40
Repligen
RGEN
$9.86B
$81.9M 1%
445,168
-5,771
-1% -$1.1M
SPGI icon
41
S&P Global
SPGI
$122B
$79.6M 0.97%
187,200
-7,813
-4% -$3.39M
UNH icon
42
UnitedHealth
UNH
$337B
$78M 0.95%
157,645
-6,109
-4% -$3.11M
PGNY icon
43
Progyny
PGNY
$2.13B
$76.2M 0.93%
1,996,595
-17,863
-0.9% -$675K
CGNX icon
44
Cognex
CGNX
$9.95B
$73.2M 0.89%
1,725,820
+5,173
+0.3% +$201K
DHR icon
45
Danaher
DHR
$147B
$72.5M 0.89%
290,494
-12,105
-4% -$2.95M
KAI icon
46
Kadant
KAI
$3.14B
$71.7M 0.87%
218,528
-7,055
-3% -$2.13M
ACVA icon
47
ACV Auctions
ACVA
$1.77B
$69.7M 0.85%
3,713,565
-34,868
-0.9% -$546K
OPCH icon
48
Option Care Health
OPCH
$3.52B
$65.7M 0.8%
1,959,860
+2,035
+0.1% +$65.9K
ENTG icon
49
Entegris
ENTG
$19.8B
$62.1M 0.76%
442,091
+102,558
+30% +$13.1M
CHE icon
50
Chemed
CHE
$6.62B
$61.2M 0.75%
95,287
-3,043
-3% -$1.85M

Similar funds

Riverbridge Partners's Q1 2024 Portfolio in Review

As of Q1 2024, Riverbridge Partners held 209 positions worth $8.2B, up 2.4% from $8B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Riverbridge Partners withdrew a net $291M in Q1 2024, closing 35 positions and reducing 110 holdings. Its most notable exit was Abbott, an estimated $1.74M position sold in full.

By sector, the portfolio is most concentrated in Technology at 39% of assets, up from 38% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Riverbridge Partners opened a new position in Fair Isaac worth $24.9M.

  • Riverbridge Partners's largest Q1 2024 buy was Fair Isaac: 19,900 shares worth $24.9M.
  • Riverbridge Partners added most to Kinsale Capital Group in Q1 2024, an estimated $28.5M increase.
  • Riverbridge Partners's biggest Q1 2024 reduction was Fastenal, cutting an estimated $45.6M.
  • Riverbridge Partners fully exited Abbott in Q1 2024, selling an estimated $1.74M.
  • Riverbridge Partners's ten largest holdings make up 29% of its $8.2B portfolio in Q1 2024.
  • Riverbridge Partners opened 7 new positions and closed 35 in Q1 2024.
  • Riverbridge Partners's portfolio value rose 2.4% quarter-over-quarter to $8.2B.

Based on Riverbridge Partners's 13F filing for Q1 2024, filed 26 Apr 2024.